Success Story: Expanding Liver Transplant Access Through Machine Perfusion Biomarkers: NIW Approved for a Saudi Arabian Research Fellow Improving Organ Selection and Post-Transplant Outcomes
Client’s Testimonial:
"Outstanding overall performance. Thank you. I think if it weren't for the delays from the recommenders and degree evaluation, this process could have been 3-4 months shorter at least."
On April 22nd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the field of Medicine (Approval Notice).
General Field: Medicine
Position at the Time of Case Filing: Research Fellow
Country of Origin: Saudi Arabia
State of Residence at the Time of Filing: Ohio
Approval Notice Date: April 22nd, 2026
Processing Time: 9 months, 8 days (Premium Processing Requested)
Case Summary:
Liver transplantation faces two competing realities. The need for donor organs remains high, yet clinicians must also avoid using grafts that carry unacceptable risk for failure or serious post-operative complications. In this case, the petition presented the client’s proposed endeavor as advancing ex vivo machine perfusion research by identifying novel biomarkers for liver graft quality and analyzing transplant outcomes. The goal was to support safer organ selection, reduce complications after surgery, and expand utilization of viable grafts that might otherwise be declined. At the time of filing, the client was continuing this work in the United States as a research fellow in a transplant-focused research role aligned with the proposed endeavor.
Research with National Importance
The NIW strategy framed the work as nationally important because better graft assessment directly affects patient survival, waitlist outcomes, and healthcare resource use. By improving how transplant teams evaluate organ viability and predict recipient risk, biomarker-driven perfusion research can increase the supply of transplantable organs while maintaining safety standards. The petition emphasized that scalable, evidence-based approaches to graft selection and post-transplant outcome analysis can strengthen U.S. transplant care and reduce preventable complications.
Academic Contributions and Recognition
To show the client was well-positioned, the petition documented 9 peer-reviewed journal articles and 38 abstracts, with 135 citations reflecting independent reliance by other researchers. The filing also highlighted that multiple publications achieved strong citation percentile performance for their publication periods, supporting field-normalized influence beyond raw totals. Professional trust was further supported through peer-review activity, with five completed reviews for selective venues. The petition also connected scholarship to practical impact by noting that the client’s biomarker findings informed clinical decision-making within a transplant practice setting.
Expert Endorsements
The petition included expert letters explaining why the client’s work on perfusion biomarkers and outcomes analysis matters beyond a single research setting and how it supports U.S. leadership in transplantation innovation. One expert stated: One expert stated:
“…[client]’s experience has allowed him to greatly advance research in organ transplantation, and his work is crucial to securing the United States’ status as a leader in medical innovation.”
This assessment reinforced the petition’s showing that the client’s contributions are recognized by specialists qualified to evaluate impact in this area and that the client is well-positioned to continue advancing the proposed endeavor.
NIW Approval and Outlook
The I-140 NIW petition was filed on July 14th, 2025, and approved on April 22nd, 2026, following a Premium Processing upgrade after filing. The approval reflected a cohesive NIW presentation that the endeavor carries substantial merit and national importance and that the client is well-positioned through a documented publication record, independent citation reliance, trusted peer-review activity, and continued research plans aligned with improving liver transplant outcomes.